Zobrazeno 1 - 10
of 79
pro vyhledávání: '"Andreas, Kerschbaumer"'
Autor:
Simonas Kecorius, Susanne Sues, Leizel Madueño, Alfred Wiedensohler, Ulf Winkler, Andreas Held, Sabine Lüchtrath, David C. Beddows, Roy M. Harrison, Mario Lovric, Vanessa Soppa, Barbara Hoffmann, Miriam Wiese-Posselt, Andreas Kerschbaumer, Josef Cyrys
Publikováno v:
Environment International, Vol 193, Iss , Pp 109086- (2024)
Studies revealed airports as a prominent source of ultrafine particles (UFP), which can disperse downwind to residential areas, raising health concerns. To expand our understanding of how air traffic-related emissions influence total particle number
Externí odkaz:
https://doaj.org/article/4e6a65bbba9d4e829445e9f720133686
Autor:
Daniel Mrak, Daniela Sieghart, Elisabeth Simader, Selma Tobudic, Helga Radner, Peter Mandl, Lisa Göschl, Maximilian Koblischke, Nikolaus Hommer, Angelika Wagner, Margareta Mayer, Lorenz Schubert, Lukas Hartl, Karin Kozbial, Philipp Hofer, Felix Kartnig, Thomas Hummel, Andreas Kerschbaumer, Thomas Deimel, Antonia Puchner, Venugopal Gudipati, Renate Thalhammer, Petra Munda, Keziban Uyanik-Ünal, Andreas Zuckermann, Gottfried Novacek, Thomas Reiberger, Erika Garner-Spitzer, Roman Reindl-Schwaighofer, Renate Kain, Stefan Winkler, Josef S. Smolen, Karin Stiasny, Gottfried F. Fischer, Thomas Perkmann, Helmuth Haslacher, Markus Zeitlinger, Ursula Wiedermann, Judith H. Aberle, Daniel Aletaha, Leonhard X. Heinz, Michael Bonelli
Publikováno v:
Nature Communications, Vol 13, Iss 1, Pp 1-9 (2022)
Optimizing COVID-19 vaccination strategies for patients under immunosuppressive medication is of high importance. In this clinical trial including non-seroconverted immunosuppressed patients, a homologous mRNA booster vaccination resulted in higher s
Externí odkaz:
https://doaj.org/article/681a28347eb1429cb5190cc8fa0a5dd3
Publikováno v:
Environmental Research: Health, Vol 2, Iss 3, p 035008 (2024)
Local policies are part of the toolbox available to decision makers to improve air quality but their effectiveness is underevaluated and underreported. We evaluate the impact of the pedestrianization of a street in the city centre of Berlin on the lo
Externí odkaz:
https://doaj.org/article/f375274fa6284fafac5e850c8e30e393
Autor:
Désirée van der Heijde, Maxime Dougados, Naveed Sattar, Tsutomu Takeuchi, Iain B McInnes, Daniel Aletaha, Tanja A Stamm, Christian Dejaco, Josef S Smolen, Gerd R Burmester, Kevin Winthrop, Michael Trauner, Angelo Ravelli, Andreas Kerschbaumer, Eva Chwala, Kastriot Kastrati, Marieke J H Voshaar
Publikováno v:
RMD Open, Vol 8, Iss 2 (2022)
Objectives Informing an international task force updating the consensus statement on efficacy and safety of biological disease-modifying antirheumatic drugs (bDMARDs) selectively targeting interleukin-6 (IL-6) pathway in the context of immune-mediate
Externí odkaz:
https://doaj.org/article/07c0e01a19cd41a7ac3ac3a49ec670ab
Autor:
Marialuisa Volta, Umberto Giostra, Giorgio Guariso, Jose Baldasano, Martin Lutz, Andreas Kerschbaumer, Annette Rauterberg-Wulff, Francisco Ferreira, Luìsa Mendes, Joana Monjardino, Nicolas Moussiopοulos, Christos Vlachokostas, Peter Viaene, Janssen Stijn, Enrico Turrini, Elena De Angelis, Claudio Carnevale, Martin L Williams, Michela Maione
Publikováno v:
PLoS ONE, Vol 17, Iss 11, p e0277428 (2022)
COVID-19 (Coronavirus disease 2019) hit Europe in January 2020. By March, Europe was the active centre of the pandemic. As a result, widespread "lockdown" measures were enforced across the various European countries, even if to a different extent. Su
Externí odkaz:
https://doaj.org/article/b1dc0d2f3f784a01b393429602a3de5f
Autor:
Christina Bal, Lisa Göschl, Ruxandra-Iulia Milos, Klaus Gerstbrein, Andreas Kerschbaumer, Marco Idzko, Daniela Gompelmann
Publikováno v:
Respiratory Medicine Case Reports, Vol 37, Iss , Pp 101650- (2022)
A 53-year old female patient with history of hypocomplementaemic urticarial vasculitis syndrome (HUVS) and polyarteritis nodosa presented with progressive dyspnoea on exertion due to emphysema. Lung function revealed a severe obstructive ventilator d
Externí odkaz:
https://doaj.org/article/f0eddfe4139c43e1b0bf16479c06dca2
Autor:
Maxime Dougados, Roy Fleischmann, Louise Falzon, Kevin Winthrop, Andreas Kerschbaumer, Wolf-Henning Boehncke, Klaus Geissler, Thomas Doerner
Publikováno v:
RMD Open, Vol 6, Iss 3 (2020)
Objectives Review of efficacy and safety of Janus kinase (JAK) inhibition in immune-mediated inflammatory diseases (IMIDs).Methods A systematic literature research (SLR) of all publications on JAK inhibitors (JAKi) treatment published until March 201
Externí odkaz:
https://doaj.org/article/d40f9c83ac5b4977926ed9f5c07fcb39
Autor:
Kevin Staats, Ilse-Gerlinde Sunk, Claudia Weidekamm, Andreas Kerschbaumer, Manuel Bécède, Gabriela Supp, Tanja Stamm, Reinhard Windhager, Josef S. Smolen, Klaus Bobacz
Publikováno v:
Therapeutic Advances in Musculoskeletal Disease, Vol 12 (2020)
Aims: Radiographic imaging is essential in the diagnosis of hand osteoarthritis (HOA); however, it is unknown whether a multiplanar examination would add essential information to dorso-palmar (dp) views alone. This study evaluated whether an addition
Externí odkaz:
https://doaj.org/article/4be1406207f64800afc855a973490683
Publikováno v:
Annals of the Rheumatic Diseases. 81:1374-1378
ObjectivesVarious hypotheses exist for the explanation of placebo response rates in randomised controlled trials (RCTs) of patients with rheumatoid arthritis with IR to methotrexate (MTX). We hypothesised that placebo responses may be related to more
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::573ae7f9ee5c2bef0880f8cfed6c00e3
https://doi.org/10.1136/annrheumdis-2021-221807
https://doi.org/10.1136/annrheumdis-2021-221807
Autor:
Michael Bonelli, Helga Radner, Andreas Kerschbaumer, Daniel Mrak, Martina Durechova, Jutta Stieger, Rusmir Husic, Peter Mandl, Josef S Smolen, Christian Dejaco, Daniel Aletaha
Publikováno v:
Annals of the Rheumatic Diseases. 81:838-844
BackgroundPolymyalgia rheumatica is the second most common inflammatory rheumatic disease of people >50 years. Glucocorticoid therapy is highly effective, but many patients require treatment for several years. Effective glucocorticoid sparing agents
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::12c4348cad61b679adae3b599334c731
https://doi.org/10.1136/annrheumdis-2021-221126
https://doi.org/10.1136/annrheumdis-2021-221126